Syros Pharmaceuticals, Inc.

CIK 1556263 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Syros Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Mar 27, 2025SCHEDULE 13D/A0001415889-25-009119
Mar 20, 202515-12G0001193125-25-059362
Mar 14, 20251440001972362-25-000314
Mar 11, 2025EFFECT9999999995-25-000632
Mar 11, 2025EFFECT9999999995-25-000633
Mar 11, 20251440001972362-25-000274
Mar 11, 2025EFFECT9999999995-25-000630
Mar 11, 2025EFFECT9999999995-25-000629
Mar 11, 2025EFFECT9999999995-25-000631
Mar 11, 2025EFFECT9999999995-25-000634
Mar 11, 2025EFFECT9999999995-25-000637
Mar 10, 2025POS AM0001193125-25-050879
Mar 10, 2025POS AM0001193125-25-050872
Mar 10, 2025S-8 POS0001193125-25-050918
Mar 10, 2025S-8 POS0001193125-25-050928
Mar 10, 2025S-8 POS0001193125-25-050897
Mar 10, 2025POS AM0001193125-25-050873
Mar 10, 2025S-8 POS0001193125-25-050898
Mar 10, 2025POS AM0001193125-25-050871
Mar 10, 2025S-8 POS0001193125-25-050913
Mar 10, 2025S-8 POS0001193125-25-050906
Mar 10, 2025POS AM0001193125-25-050876
Mar 10, 2025POS AM0001193125-25-050874
Mar 10, 2025250001193125-25-050859
Mar 10, 2025S-8 POS0001193125-25-050902